Serum protease cleavage of Bacillus anthracis protective antigen
- PMID: 1593265
- DOI: 10.1099/00221287-138-3-543
Serum protease cleavage of Bacillus anthracis protective antigen
Abstract
The protective antigen component of anthrax lethal toxin, produced in vitro, has a molecular mass of 83 kDa. Cell-culture studies by others have demonstrated that upon binding of the 83 kDa protective antigen to cell-surface receptors, the protein is cleaved by an unidentified cell-associated protease activity. The resultant 63 kDa protein then binds lethal factor to form lethal toxin, which has been proposed to be internalized by endocytosis. We found that, in the blood of infected animals, the protective antigen exists primarily as a 63 kDa protein and appears to be complexed with the lethal factor component of the toxin. Conversion of protective antigen from 83 to 63 kDa was catalysed by a calcium-dependent, heat-labile serum protease. Except for being complexed to protective antigen, there was no apparent alteration of lethal factor during the course of anthrax infection. The protective antigen-cleaving protease appeared to be ubiquitous among a wide range of animal species, including primates, horses, goats, sheep, dogs, cats and rodents.
Similar articles
-
Activity of the Bacillus anthracis 20 kDa protective antigen component.BMC Infect Dis. 2008 Sep 22;8:124. doi: 10.1186/1471-2334-8-124. BMC Infect Dis. 2008. PMID: 18808698 Free PMC article.
-
Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo.FEMS Immunol Med Microbiol. 2011 Jun;62(1):11-22. doi: 10.1111/j.1574-695X.2011.00782.x. Epub 2011 Feb 2. FEMS Immunol Med Microbiol. 2011. PMID: 21231965
-
Anthrax protective antigen cleavage and clearance from the blood of mice and rats.Infect Immun. 2007 Nov;75(11):5175-84. doi: 10.1128/IAI.00719-07. Epub 2007 Aug 27. Infect Immun. 2007. PMID: 17724066 Free PMC article.
-
Interactions between anthrax toxin receptors and protective antigen.Curr Opin Microbiol. 2005 Feb;8(1):106-12. doi: 10.1016/j.mib.2004.12.005. Curr Opin Microbiol. 2005. PMID: 15694864 Review.
-
The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.Mol Aspects Med. 2009 Dec;30(6):431-8. doi: 10.1016/j.mam.2009.07.006. Epub 2009 Aug 7. Mol Aspects Med. 2009. PMID: 19665472 Review.
Cited by
-
Anthrax lethal toxin co-complexes are stabilized by contacts between adjacent lethal factors.J Gen Physiol. 2016 Oct;148(4):273-5. doi: 10.1085/jgp.201611681. J Gen Physiol. 2016. PMID: 27670896 Free PMC article. No abstract available.
-
Rapid vascular responses to anthrax lethal toxin in mice containing a segment of chromosome 11 from the CAST/Ei strain on a C57BL/6 genetic background.PLoS One. 2012;7(7):e40126. doi: 10.1371/journal.pone.0040126. Epub 2012 Jul 5. PLoS One. 2012. PMID: 22792226 Free PMC article.
-
Anthrax lethal toxin impairs innate immune functions of alveolar macrophages and facilitates Bacillus anthracis survival.Infect Immun. 2006 Sep;74(9):5029-34. doi: 10.1128/IAI.00275-06. Infect Immun. 2006. PMID: 16926394 Free PMC article.
-
Identification of molecular-mimicry-based ligands for cholera diagnostics using magnetic relaxation.Bioconjug Chem. 2011 Feb 16;22(2):307-14. doi: 10.1021/bc100442q. Epub 2011 Jan 12. Bioconjug Chem. 2011. PMID: 21226491 Free PMC article.
-
Anthrax toxin receptor drives protective antigen oligomerization and stabilizes the heptameric and octameric oligomer by a similar mechanism.PLoS One. 2010 Nov 8;5(11):e13888. doi: 10.1371/journal.pone.0013888. PLoS One. 2010. PMID: 21079738 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous